News & Analysis as of

Funding Life Sciences

Latham & Watkins LLP

Life Sciences Product Development Needs More Creative Fundraising

Latham & Watkins LLP on

The life sciences industry depended historically on public offerings for fundraising to support costs of developing therapeutic pharmaceutical and biologic products. The average cost of discovering and developing these...more

American Conference Institute (ACI)

[Event] The National Forum on IP Funding and Tech Strategies for Novel Therapeutic Modalities and Gene Therapies - March 21st -...

Hosted by American Conference Institute (ACI), the National Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities and Gene Therapies will highlight leveraging technology, safeguarding IP, and securing...more

Allen Matkins

Life Sciences Real Estate Update -1.06.23 #1

Allen Matkins on

California’s lab and biotech industries provide 435,693 jobs that generate $376 billion in total economic output, according to a new report from Biocom California, an association representing life sciences companies and...more

Cozen O'Connor

Broad Street Brief: Councilmember Domb Resigns, Green Equity Initiative Gets Pushed, African American Museum Will Move

Cozen O'Connor on

Philadelphia City Councilmember Domb Resigns- On Monday, City Councilmember Allan Domb announced that he is resigning, citing his intent to evaluate a 2023 mayoral run. In an interview with The Philadelphia Inquirer, the...more

Manatt, Phelps & Phillips, LLP

PCORI Releases Draft Research Priorities for Public Comment

On January 6, 2022, the Patient-Centered Outcomes Research Institute (PCORI) released its Proposed Research Agenda, linked to its newly adopted National Priorities for Health that was developed during a comprehensive...more

Goodwin

Client Conversation: Square Mile Capital

Goodwin on

As investors’ demand for life sciences real estate grows at a rapid pace, lenders are actively seeking to lend in this space. Goodwin partner Jarrid King spoke with Eric Juster, Vice President, Investments at Square Mile...more

Fenwick & West Life Sciences Group

Midway Through 2021, Digital Health Startups Sprint Past 2020 Records

At the end of Q1 2021, our friends at Rock Health noted the record-breaking $6.7 billion raised by digital health startups and declared the sector “all grown up.” The additional $8 billion raised in the second quarter of this...more

Rothwell, Figg, Ernst & Manbeck, P.C.

Capsida Biotherapeutics Debuts with $140 Million of Capital for its AAV Gene Therapies

Capsida Biotherapeutics Inc.—a  Thousand Oaks, CA-based emerging biotechnology company—recently emerged from stealth mode with $ 140 million in start-up capital. Capsida secured a $50 million Series A commitment from Versant...more

Latham & Watkins LLP

Fast Track to IPO: Why Are Series A Startups Snatching Topflight CFOs?

Latham & Watkins LLP on

Startups and scale-ups in Europe’s tech and life sciences sectors have flourished dramatically over the past year, fueled by pandemic-induced demand and a wall of investor cash. Early funding rounds are getting bigger, while...more

Lowenstein Sandler LLP

Funding Life Sciences: Where The Opportunities And Resources Are In 2021 And Beyond

Lowenstein Sandler LLP on

Early-stage and small to midsize private and public companies in the life sciences sector began 2020 on a high note. Funding, particularly in the biotechnology sector, was pouring into the industry. Even several months into...more

Arnall Golden Gregory LLP

Money, Money, Money . . . . It’s A Rich Man’s World: Getting Funding for COVID-19-Related Medical Products

While many of us are justifiably focused on the negative aspects of the COVID-19 pandemic, one positive result has been the way in which the life sciences community has answered the call to develop lifesaving medical...more

Mayer Brown Free Writings + Perspectives

Global Healthcare Financing Trends During COVID-19

During the first quarter of 2020, venture funding levels in the global healthcare and life sciences sector has increased 4% by dollars raised, quarter-over-quarter, despite the turbulent COVID-19 environment. According to a...more

Goodwin

Answers to FAQ about the UK Government’s ‘Future Fund’ Financing Package

Goodwin on

On 20 April 2020, the UK government (“Government”) announced the Future Fund, providing financing to UK companies (including to start-ups and scale-ups in the technology and life sciences sectors) in the form of a convertible...more

Mintz - ML Strategies

FY18 Massachusetts Budget Update: Governor Baker Signs FY18 Budget

Mintz - ML Strategies on

On Monday, July 17th, Governor Charlie Baker signed a budget for FY2018 that includes $39.4 billion in spending. This comes ten days after the Legislature approved a state budget with a $40.2 billion bottom line. The Senate...more

McDonnell Boehnen Hulbert & Berghoff LLP

Second Quarter Venture Funding Increases 20% from First Quarter

Earlier this year, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report on venture funding for the second quarter of...more

McDonnell Boehnen Hulbert & Berghoff LLP

Venture Funding Reaches Highest Level in More Than a Decade

Last month, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report on venture funding for 2014. The report, which is...more

Mintz

Financing Trends in Life Sciences – Interview with Bill Whelan, Member, Mintz Levin

Mintz on

Attorney Bill Whelan, Co-chair of Mintz Levin's Life Sciences Practice, discusses what is driving financing trends in the life sciences....more

17 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide